- Home
- ANY vs SCNX Comparison
ANY vs SCNX Comparison
Compare ANY & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANY | SCNX |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | 9 |
| Industry | Finance: Consumer Services | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1M | 15.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANY | SCNX |
|---|---|---|
| Price | $2.12 | $0.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $30.00 | $1.50 |
| AVG Volume (30 Days) | 614.4K | ★ 886.3K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,181,000.00 | N/A |
| Revenue This Year | $15.62 | $1,097.38 |
| Revenue Next Year | N/A | $239.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $0.24 |
| 52 Week High | $6.20 | $2.60 |
Technical Indicators
Market Signals| Indicator | ANY | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 50.36 | 47.82 |
| Support Level | $1.30 | $0.37 |
| Resistance Level | $2.48 | $0.43 |
| Average True Range (ATR) | 0.28 | 0.03 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 74.72 | 32.30 |
Price Performance
Historical ComparisonAbout ANY Sphere 3D Corp.
Sphere 3D Corp is engaged in the Bitcoin mining business. The company has established an enterprise-scale mining operation through the procurement of mining equipment and partnering with experienced service providers. It generates revenue from mining and selling Bitcoin.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.